We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
92 hedge funds and large institutions have $226M invested in Regulus Therapeutics in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
186% more call options, than puts
Call options by funds: $11.4M | Put options by funds: $3.97M
35% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 23
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
0% more funds holding
Funds holding: 92 → 92 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
40% less capital invested
Capital invested by funds: $377M → $226M (-$151M)
Holders
92
Holders Change
–
Holders Change %
0%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
16
Increased
31
Reduced
23
Closed
15
Calls
$11.4M
Puts
$3.97M
Net Calls
+$7.38M
Net Calls Change
-$6.95M
Top Buyers
| 1 |
Axa
Paris,
France
|
+$7.93M |
| 2 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$7.33M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$6.43M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.26M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.13M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$20M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.43M |
| 3 |
Jennison Associates
New York
|
-$4.46M |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$3.14M |
| 5 |
Goldman Sachs
New York
|
-$1.17M |
